Visión generalGráficoNoticiasTraderScreen

HSBC Knock-Out INCY/  DE000HS7TLA2  /

Frankfurt Zert./HSBC
14/11/2024  11:00:48 Diferencia-0.060 Bid14/11/2024 Ask14/11/2024 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
2.020EUR -2.88% 2.020
Volumen de oferta: 25,000		 2.070
Tamaño/ Volumen/ Formato de Ask: 25,000		 Incyte Corporation 59.2897 USD 31/12/2078 Call
GlobeNewswire 27/08 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 27/08 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 16/08 China Medical System （00867） Released its 2024 Interim Results: Steady Increase in Revenue and Profi...
GlobeNewswire 06/08 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
GlobeNewswire 01/08 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire 30/07 MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboratio...
Newsfile Corp 17/07 Analysts Hunt for Undervalued Biotech Stocks
TeleTrader 09/07 US closes mostly higher after Fed's chair testimony
GlobeNewswire 25/06 China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...
GlobeNewswire 29/05 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 28/05 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors
GlobeNewswire 09/05 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire 08/05 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 30/04 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
GlobeNewswire 02/04 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...
GlobeNewswire 01/04 CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...
GlobeNewswire 28/02 Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire 09/01 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
TeleTrader 12/12/2023 Wall Street closes higher after inflation report
GlobeNewswire 09/12/2023 CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
GlobeNewswire 16/11/2023 CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...
GlobeNewswire 02/11/2023 Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
GlobeNewswire 23/10/2023 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...
GlobeNewswire 12/10/2023 Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032
GlobeNewswire 27/09/2023 Arcutis Appoints L. Todd Edwards as Chief Commercial Officer